GUM Remote Testing v4.0
NCT06244966 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-04-10
Summary
Capillary blood sample results are compared to venous blood results
Conditions
- HIV Infections
- Syphilis Infection
- Hepatitis B and Hepatitis C
Interventions
- DIAGNOSTIC_TEST
-
HIV diagnostic testing
Finger-prick capillary blood will be tested alongside venous blood
Sponsors & Collaborators
-
Royal Devon and Exeter NHS Foundation Trust
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-31
- Primary Completion
- 2025-05-31
- Completion
- 2025-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
NCT00659789 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo
NCT02457689 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
NCT00000675 ·Status: COMPLETED ·Phase: PHASE1
-
Germinal Transmission After Endogenization of HIV Sequences Without a Competent Virus for Replication and a Potential Protective Role
NCT03640923 ·Status: UNKNOWN ·Phase: NA
-
Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
NCT02707900 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
NCT06071767 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test
NCT06368453 ·Status: COMPLETED ·Phase: NA
-
Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults
NCT04983030 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
HIV-1 Vaccine Test in Uninfected Adult Volunteers
NCT00047931 ·Status: COMPLETED ·Phase: PHASE1
-
Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood
NCT04810559 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected
NCT05075044 ·Status: UNKNOWN ·Phase: PHASE4
-
Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
NCT02231281 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants
NCT03735849 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes
NCT02075983 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults
NCT03205917 ·Status: COMPLETED ·Phase: PHASE1
-
Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine
NCT01827397 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants
NCT04212091 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4
-
Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults
NCT03228069 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants
NCT05217641 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
NCT01783977 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
NCT00125099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
NCT00000976 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)
NCT01705223 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART
NCT05604209 ·Status: COMPLETED ·Phase: PHASE1